The steroidal saponin, pectinioside A, was isolated from the starfish, Patiria pectinifera. When it was subcutaneously injected into mice with ovalbumin (OVA), it facilitated the production of OVA-specific total IgG and IgG1 but not IgG2a. To our knowledge, this is the first report suggesting that starfish saponin has the potential to be an immunological adjuvant, stimulating Th2 type immune response.
Saponins are a generic name for steroid or triterpene glycosides. Plants are the main sources of saponins, which are believed to be defensive molecules that act against pathogens, pests and predators. The immense structural diversity gives them a variety of bioactivities, resulting in the utilization of saponin-containing plants as natural drugs and folk medicines [1] . One of the remarkable activities of saponins is the immunological adjuvant activity they possess [2] . Immunological adjuvants are defined as substances that are added to a vaccine to enhance and/or modulate the immunogenicity of antigens. The adjuvants are important in the design of effective vaccines, however, the clinically available adjuvants are few in number [3] . Although there is no saponin approved as vaccine adjuvant, QS21, which is one of the plant saponins derived from Quillaja saponaria, is under clinical trials as a component of vaccines against malaria, cancer, human immunodeficiency virus (HIV), influenza, etc [3] . In some of these trials, the complexes of QS21 and cholesterol are used to make the saponin less toxic and stable without reducing the adjuvant activity. Thus, saponins are the hopeful candidates for a new immunological adjuvant.
Although plants have been the main sources of bioactive saponins, starfish are also a desirable source, because about 400 structurally different saponins have been purified from starfish and their diverse bioactivities such as cytotoxic, hemolytic, ichthyotoxic, antifungal, antiviral and anti-inflammatory activities have been reported [4] . Recently, we have investigated the potential of starfish saponins as immunological adjuvants and found that the crude extract from two common littoral species, Asterias amurensis and Patiria (or Asterina) pectinifera, promoted antibody production when they were subcutaneously injected into mice together with the antigen, ovalbumin (OVA) [5] . Accordingly, in this research, we purified the saponin from P. pectinifera and evaluated its adjuvant activity.
First, the components of the methanol extract of P. pectinifera were separated by the liquid phase separation, silica gel column chromatography and reverse phase HPLC. The major compound with hemolytic activity was isolated, and its spectroscopic data (MS and NMR) were completely matched with the reported values for pectinioside A ( Figure 1A ) [6] .
The hemolytic activity of pectinioside A was measured quantitatively (EC 50 value: 21 ± 1 μg/mL) and it was slightly weaker than the positive control, Quil-A (EC 50 value: 17 ± 0 μg/mL, Figure 1B ). This result suggested a relatively lower cytotoxicity of pectinioside A. Quil-A is a mixture of Quillaja saponins, including QS21. Previous research has shown that the hemolytic activities of the major saponin components were slightly different, as the EC 50 values are 25 ± 3 μg/mL for QS17, 15 ± 3 for QS18 and 7 ± 2 for QS21 [7] . In this research, we used Quil-A to show the average activity of Quillaja saponins, and our hemolytic data (EC 50 : 17 ± 0 μg/mL for Quil-A) was consistent with those values.
To investigate the immunological adjuvant activity, pectinioside A was subcutaneously injected into mice together with the antigen, OVA. Subsequently, the amount of OVA-specific IgG in mouse sera was measured by enzyme-linked immunosorbent assay (ELISA). In this experiment, Quil-A was used again as the positive control, because the adjuvant activities of Quillaja saponins were thought to be similar to each other and Quil-A could be regarded as the representative [7] . The production of OVA-specific IgG was significantly facilitated by both pectinioside A and Quil-A ( Figure  2A ). Furthermore, pectinioside A selectively enhanced the production of OVA-specific IgG1 but not IgG2a, and the selective enhancement was close to the positive control ( Figure 2B and 2C) . These results clearly indicated the immunological adjuvant activity of pectinioside A and suggested that this compound preferentially stimulated Th2 type immune response because IgG1 and IgG2a were known as the markers for Th2 and Th1 type immune response respectively.
Figure 2:
Immunological adjuvant activity of pectinioside A. OVA-specific total IgG (A), IgG1 (B) and IgG2a (C) in the mouse sera were detected by ELISA. Mice were subcutaneously immunized with PBS, PBS + OVA, Quil-A (QA) + OVA or pectinioside A (PA) + OVA. Each value represented the average ± SD of each group of 10 mice. According to one-way ANOVA followed by Tukey's range method, these groups were significantly discriminated as "a", "b", and "c" (p < 0.05).
Besides Quil-A, most plant saponins have the potential to stimulate both Th1 and Th2 type immune responses against OVA. Ginsenosides (from Panax notoginseng), glycyrrhiza saponins (Glycyrrhiza uralensis), gypenosides (Gynostemma pentaphyllum), kinmoonosides (Acacia concinna), platycodins (Platycodon grandiflorum), saikosaponins (Bupleurum chinense) and soyasaponins (Glycine max) promoted both OVA-specific IgG1 and IgG2b productions in previous studies [2, 8] . These facts suggest that the saponin-based adjuvants elicit the balanced Th1 and Th2 type immune responses and they are applicable to the vaccines against wide range of diseases. However, the stimulation of Th2 type immune response is more important than that of Th1 to eliminate specific pathogens such as helminthes. Therefore, pectinioside A is valuable in the design of more efficacious vaccines against specific pathogens.
Experimental
Extraction, purification and identification of pectinioside A: P. pectinifera (6 kg) were collected at the coast of Hitachinaka, Ibaraki Japan. They were cut into small pieces (≈ 1.0 cm 3 ), and extracted with 9 L methanol overnight at room temperature. The extract was paper-filtrated, and the residual substance was re-extracted with 3 L methanol. After the paper-filtration, the extracts were combined and dried. The resulting material (163 g) was dissolved in 500 mL water, and defatted four times with 500 mL n-hexane and five times with 500 mL ethyl acetate, followed by three times extraction with 500 mL n-butanol. The extracts were combined, dried (8.1 g) and separated by a silica gel chromatography with chloroformmethanol-water (7:3:0.3 and then 6:4:0.4) into four fractions. The third fraction (the first half of 6:4:0.4 elution, 340 mg) had hemolytic activity and was further separated by HPLC (Wakosil-II 5C18 HG Prep, 20 mm×250 mm, 60% methanol-water, 3 mL/min). Pectinioside A (26.2 mg) was then isolated as the main compound and identified by its spectroscopic data (MS and NMR) [6] .
Assay of hemolytic activity:
The samples were dried and dissolved in phosphate buffered saline (PBS, Wako Pure Chemical, Japan). For the qualitative detection, each sample was absorbed into a 5 mm square filter paper and put on sheep blood agar (Eiken Chemical, Japan) to observe the lysis of red blood cells. For the quantitative measurement, the sample was added into the suspension of sheep blood cells, which was washed three times with PBS and adjusted at 2 × 10 9 red blood cells/mL in PBS. After 30 minutes incubation at room temperature, the supernatant was collected by centrifugation (100 × g) and diluted three-fold with PBS. The light absorbance at 415 nm (OD 415 ) was measured to detect the amount of hemoglobin, released by hemolysis. The results of each agent were statistically compared by the Student's t-test.
Investigation of immunological adjuvant activity:
Twenty-five µg OVA (Sigma, USA) and 50 µg pectinioside A were dissolved in 100 µL PBS and this solution was subcutaneously injected into each mouse (Jcl:ICR, six-week old, female, CLEA Japan, Japan) on day 1 and 14. Also, 100 µL PBS and 100 µL PBS containing 25 µg OVA were used as the negative controls, and 100 µL PBS containing both 25 µg OVA and 50 µg Quil-A (Saponin from Quillaja bark, Sigma) was used as the positive control. Ten mice were respectively used for these 4 conditions. On day 28, the sera were collected to measure the OVA-specific IgG by ELISA as described before [5] . The results of each treatment were compared by the statistical analysis, one-way ANOVA followed by Tukey's range method. This animal experiment was approved by the Institutional Animal Care and Use Committee of Dokkyo Medical University (ID No. 0906).
